DEF: Nature's Sunshine Products Sets Date for 2025 Annual Shareholder Meeting
Proxy Statement
Nature's Sunshine Products will hold its 2025 Annual Meeting of Shareholders on April 30, 2025, to elect directors, approve executive compensation, and ratify the appointment of its independent accounting firm.
Summary
- Nature's Sunshine Products, Inc. will hold its 2025 Annual Meeting of Shareholders on April 30, 2025, at its principal executive offices in Lehi, Utah.
- Shareholders of record as of February 21, 2025, are entitled to vote on the election of eight directors, an advisory resolution on executive compensation, and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2025.
- The Board of Directors recommends voting 'For' all nominees for director and 'For' the advisory resolution on executive compensation and the ratification of the accounting firm.
- The company's 2024 performance highlights include net sales of $454.4 million, net income of $7.9 million, and adjusted EBITDA of $40.3 million.
- The proxy materials are being sent to shareholders on or about March 20, 2025.
- The company's Board consists of a majority of independent directors and has four standing committees: Audit, Compensation, Governance, and Risk Management.
- The company has stock ownership guidelines for directors and executive officers and prohibits hedging, pledging, and short sales of company stock.
Sentiment
Score: 7
Explanation: The document is generally positive, outlining the company's plans for the annual meeting and highlighting some positive financial results. However, it also acknowledges certain challenges and risks, resulting in a moderately positive sentiment score.
Positives
- The Board is composed of experienced and qualified individuals, with a majority being independent.
- The company has established corporate governance guidelines and a code of ethics to ensure ethical business conduct.
- The company's compensation programs are designed to reward performance and align with shareholder value creation.
- The company has stock ownership guidelines for directors and executive officers, promoting long-term alignment with shareholders.
- The company's Audit Committee is comprised of independent directors and financial experts.
- The company's compensation committee has from time to time retained the services of Fredric W. Cook & Co., Inc. ('F.W. Cook'), a leading compensation consulting firm, to provide advice and recommendations regarding the Company's compensation programs, including equity compensation practices and cash compensation structure for executive officers.
Negatives
- Richard Moss will not stand for re-election at the Annual Meeting.
- Christopher Teets will not stand for re-election at the Annual Meeting due to the Company's Corporate Governance Guidelines and his completion of years of service on the Board.
- Due to a recent increase in director grant values, and a drop in stock price, some directors have fallen out of compliance with the stock ownership guidelines.
Risks
- The document includes forward-looking statements that are subject to risks and uncertainties.
- The company's performance is subject to various internal and external risks, including legal and regulatory requirements, distributor compliance, and cybersecurity threats.
- The company's compensation programs could potentially encourage excessive risk-taking, although the company believes this is unlikely.
Future Outlook
The document contains forward-looking statements relating to the company's objectives, plans, and strategies, which are subject to risks and uncertainties.
Management Comments
- Terrence Moorehead, President and Chief Executive Officer, expresses pleasure in inviting shareholders to the 2025 Annual Meeting and encourages them to vote.
- The Compensation Committee and Management are focused on a compensation structure that is competitive and fair and focuses on performance rather than entitlements.
Industry Context
Nature's Sunshine Products operates in the consumer products and direct selling industry, facing competition from other companies in the specialty retail and personal product sectors.
Comparison to Industry Standards
- The Compensation Committee engaged F.W. Cook to conduct a study with a peer group consisting of 15 publicly traded U.S. based specialty retail and personal product companies to perform new market comparisons of our executive compensation program and to prepare its 2022 Executive Compensation Report for setting 2022, 2023 and 2024 compensation.
- The companies in the peer group were chosen in consultation with the Compensation Committee based on objective industry classifications, annual revenue and market capitalization during 2020 (the time at which they made pay decisions disclosed in the compensation section of their 2021 proxy statements).
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chairman of the Board | Richard Moss | TBD | Following the Annual Meeting | Mr. Moss's decision not to stand for re-election |
| Director | Christopher Teets | TBD | Following the Annual Meeting | Completion of years of service on the Board |
Stakeholder Impact
- Shareholders are encouraged to participate in the Annual Meeting and vote on the proposals.
- The company's performance and governance practices impact its employees, customers, and other stakeholders.
Next Steps
- Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
- The company will hold its Annual Meeting of Shareholders on April 30, 2025.
- The Board will consider the outcome of the advisory vote on executive compensation when making future compensation decisions.
Key Dates
| Date | Description |
|---|---|
| 2007-02-02 | Deloitte & Touche LLP engaged as independent registered public accounting firm |
| 2012-08-01 | Shareholders approved the Amended and Restated Natures Sunshine Products, Inc. 2012 Stock Incentive Plan |
| 2015-01-14 | Shareholders approved an amendment to the 2012 Incentive Plan to increase the number of shares available for issuance |
| 2017-06 | Robert Straus appointed as Director |
| 2018-10-01 | Terrence Moorehead appointed as President and Chief Executive Officer |
| 2020-07 | Heidi Wissmiller appointed as Director |
| 2022-01 | Curtis Kopf appointed as Director |
| 2022-05 | Martin Gonzalez appointed as Executive Vice President of Global Supply Chain Operations |
| 2022-06 | Rong Yang appointed as Director |
| 2022-12 | Shane Jones appointed the Company's Executive Vice President, Chief Financial Officer |
| 2023-06 | Kevin Herbert joined Natures Sunshine as Executive Vice President, President North America |
| 2024-03-11 | Time-based Restricted Stock Units (RSU) were granted to our NEOs |
| 2024-05-06 | The Board approved a grant of 5,236 RSUs for each non-executive director |
| 2024-09 | Kevin Fuller named Global Chief Marketing Officer of the Company |
| 2024-11 | Steven Fasching appointed to the Board |
| 2025-01 | Katie May appointed to the Board |
| 2025-02-04 | Richard Moss notified the Board of his decision not to stand for re-election at the Annual Meeting |
| 2025-02-21 | Record date for the Annual Meeting |
| 2025-03-11 | Annual report on Form 10-K filed with the SEC |
| 2025-03-20 | Proxy solicitation materials are being sent to shareholders |
| 2025-04-30 | 2025 Annual Meeting of Shareholders |
| 2025-11-20 | Deadline to submit a shareholder proposal for the 2026 Annual Meeting |
| 2025-12-31 | Earliest date to submit a proposal at our 2026 Annual Meeting |
| 2026-01-30 | Latest date to submit a proposal at our 2026 Annual Meeting |
| 2026-04-30 | Anticipated date of 2026 Annual Meeting of Shareholders |
| 2029 | Next vote on the frequency of the say on pay vote will be held at the 2029 Annual Meeting |
Keywords
shareholders, directors, compensation, governance, proxy statement, annual meeting, executive officers, audit committee, stock ownership, Nature's Sunshine Products
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.